Skip Nav Destination
Continuing Medical Education (CME) questions|
December 20, 2012
Continuing Medical Education (CME) questions: novel prognostic score of thrombosis in ET
CME
Blood (2012) 120 (26): 5252.
Connected Content
A related article has been published:
Calreticulin mutation does not modify the IPSET score for predicting the risk of thrombosis among 1150 patients with essential thrombocythemia
Citation
Continuing Medical Education (CME) questions: novel prognostic score of thrombosis in ET. Blood 2012; 120 (26): 5252. doi: https://doi.org/10.1182/blood-2012-11-469890
Download citation file:
December 20 2012
Advertisement intended for health care professionals
Cited By
Advertisement intended for health care professionals
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal